Abstract
The COVID-19 pandemic has necessitated the development of accurate models to predict disease dynamics and guide public health interventions. This study leverages the COVASIM agent-based model to simulate 1331 scenarios of COVID-19 transmission across various social settings, focusing on the school, community, and work contact layers. We extracted complex network measures from these simulations and applied deep learning algorithms to predict key epidemiological outcomes, such as infected, severe, and critical cases. Our approach achieved an R2 value exceeding 95%, demonstrating the model’s robust predictive capability. Additionally, we identified optimal intervention strategies using spline interpolation, revealing the critical roles of community and workplace interventions in minimizing the pandemic’s impact. The findings underscore the value of integrating network analytics with deep learning to streamline epidemic modeling, reduce computational costs, and enhance public health decision-making. This research offers a novel framework for effectively managing infectious disease outbreaks through targeted, data-driven interventions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Financial Disclosure statement EpilabKI is funded through the Bavarian stated Ministery for Sciences and the Arts research. The funder provided support in the form of salaries for authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* Caroline.Alves{at}th-ab.de
